Warning on risks: Financial contracts for difference are complex instruments and are associated with a high risk of rapid financial losses due to leverage. On 76.44% of retail investor accounts, financial losses occur when trading financial contracts for difference with this provider. You should consider whether you understand how financial contracts for difference work, and whether you can afford to take the high risk of suffering financial losses. Please read the Risk Disclosures.
Instruments
2/3/2026
Anglo American on 20 February 2026 wrote down the value of De Beers by $2.3 billion and brought the carrying value of the diamond division to $2.3 billion. The group also reported a net loss of $3.7 billion but kept EBITDA operating profit adjusted for one-off items at $6.4 billion and confirmed further progress on the separation of De Beers, which the market reads as an acceleration of capital reallocation toward copper.[1]
24/2/2026
Novo Nordisk shares fell by approximately 15 to 20% after the release of a weaker outlook for 2026, which pushed down the valuation even though demand for Ozempic and Wegovy and for new oral GLP1 therapies remains strong.* At the same time, it is a company with a dividend yield of around 3.8% and a conservative payout ratio of approximately 50%, while consensus target prices still indicate double-digit percentage upside compared with the current share price. [1] [1]
16/2/2026
Texas Instruments is entering a new chapter of its story in the semiconductor industry. The company has announced that it is acquiring Silicon Labs, one of the leaders in wireless chips and IoT solutions, for approximately $7.5 billion in cash. This is one of the largest transactions in the history of Texas Instruments, which can fundamentally change the balance of power in the segment of smart devices, the industrial Internet of Things, and edge AI.[1]Do you have any questions?
We will be happy to help you.
Our support team is ready to help you. Call or write - we are here for you.